scholarly journals Effect of Erythrocyte Thiopurine Methyltransferase (TPMT) Activity on Azathioprine Immunosuppression Therapy in Renal Transplant Recipients

2000 ◽  
Vol 8 (1) ◽  
pp. 60
Author(s):  
Joo-Youn Cho ◽  
Kyun-Seop Bae ◽  
Kyung-Sang Yu ◽  
So-Young Yi ◽  
Sang-Joon Kim ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Tpmt Activity ◽  
Renal Transplant Recipients ◽  
Thiopurine Methyltransferase ◽  
Transplant Recipients ◽  
Immunosuppression Therapy

Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy

2003 ◽  
pp. 994-998 ◽  
Author(s):  
Maria T. Sartori ◽  
Paolo Rigotti ◽  
Francesco Marchini ◽  
Luca Spiezia ◽  
Nicola Baldan ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Fibrinolytic Capacity ◽  
Immunosuppression Therapy

scholarly journals Monitoring Azathioprine Therapy in Paediatric Renal Transplant Recipients with Thiopurine Methyltransferase

1999 ◽  
Vol 45 (4, Part 2 of 2) ◽  
pp. 65A-65A
Author(s):  
Thierry Dervieux ◽  
Yves Medard ◽  
Veronique Baudoin ◽  
Chantal Loirat ◽  
Evelyne Jacqz-Aigrain
Keyword(s):  
Renal Transplant ◽  
Renal Transplant Recipients ◽  
Thiopurine Methyltransferase ◽  
Transplant Recipients ◽  
Azathioprine Therapy

scholarly journals Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case report

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jing Li ◽  
Gang Chen ◽  
Mingmin Zhang ◽  
Shenghao Tu ◽  
Chao Chen
Keyword(s):  
Renal Transplant ◽  
Antiviral Treatment ◽  
Reference Value ◽  
Severe Pneumonia ◽  
Disease Spread ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Case Presentation ◽  
Clinical Presentations ◽  
Immunosuppression Therapy

Abstract Background The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome Coronavirus-2 has spread rapidly worldwide and disease spread is currently increasing. Data on the clinical picture of transplant recipients and management of the anti-rejection immunosuppressive therapy on COVID-19 infection are lacking. Case presentation We report two cases of COVID-19 infection in renal transplant recipients with variable clinical presentations. The first patient presented with mild respiratory symptoms and a stable clinical course. The second patient had more severe clinical characteristics and presented with severe pneumonia and multi-organ failure. Both patients received a combination therapy including antiviral treatment and reduced immunosuppression therapy and finally recovered. Conclusions We report COVID-19 infection in two renal transplant recipients with a favorable outcome but different clinical courses, which may provide a reference value for treating such patients.

Sign in / Sign up

Export Citation Format

Share Document